Joel Isaacson & Co’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Buy
1,345
+135
+11% +$37.3K 0.01% 383
2026
Q1
$357K Hold
1,210
0.01% 334
2025
Q4
$330K Hold
1,210
0.01% 344
2025
Q3
$327K Hold
1,210
0.01% 336
2025
Q2
$334K Hold
1,210
0.01% 310
2025
Q1
$321K Hold
1,210
0.01% 306
2024
Q4
$281K Hold
1,210
0.01% 308
2024
Q3
$267K Sell
1,210
-245
-17% -$50.7K 0.01% 304
2024
Q2
$286K Hold
1,455
0.02% 284
2024
Q1
$313K Buy
+1,455
New +$306K 0.02% 270
2014
Q4
Sell
-111
Closed -$9K 639
2014
Q3
$9K Buy
+111
New +$8.37K ﹤0.01% 496

Other funds holding CME

Joel Isaacson & Co's CME Position: Q2 2026 in Review

Joel Isaacson & Co increased its CME Group (CME) stake by 11% in Q2 2026, buying an estimated $37.3K and bringing the position to 1,345 shares worth $297K. The position accounts for 0.01% of the portfolio, ranked #383.

Joel Isaacson & Co first reported a position in CME in Q3 2014 and has held it in 11 quarters since. The position peaked at $357K in Q1 2026. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Joel Isaacson & Co held 1,345 shares of CME Group worth $297K as of Q2 2026.
  • Joel Isaacson & Co bought 135 CME Group shares in Q2 2026, an estimated $37.3K.
  • CME Group made up 0.01% of Joel Isaacson & Co's portfolio in Q2 2026, its #383 holding.
  • Joel Isaacson & Co first reported a position in CME Group in Q3 2014 and has held it in 11 quarters since.
  • Joel Isaacson & Co's CME Group position peaked at $357K in Q1 2026.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.